An experimental drug that uses messenger RNA to deliver a vaccine customized to a patient’s tumors effectively prevented skin cancer recurrence in a ... Show more
washingtonpost.com
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
vaccine that transfects synthetic RNA, reprogramming cells to make foreign protein that stimulates an adaptive immune response
Similar to This
Previous
Moderna Crashes 20% On Reportedly Leaked Cancer Vaccine Data: Moderna stock crashed Thursday after a third-party leaked the purported cancer vaccine data ahead ...
investors.com/news/technology/moderna-stock-merck-stock-cancer-vaccine-data/
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%: Markers released top-line results today after previously reporting the trial ...
arstechnica.com/health/2026/10/personalized-mrna-cancer-vaccine-cut-melanoma-death-recurrence-by-42/
What Doctors Want You to Know About the New “Personalized” Cancer Vaccine Making Headlines
womenshealthmag.com/health/a73547380/melanoma-personalized-vaccine/
A new cancer vaccine may keep melanoma from coming back: A personalized mRNA vaccine paired with Keytruda may help keep skin cancer from returning after surgery ...
sciencenews.org/article/cancer-vaccine-melanoma-treatment-mrna
Moderna, Merck breakthrough could usher in wave of cancer vaccines: Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at ...
edition.cnn.com/2026/08/21/health/mrna-cancer-vaccines-wave
What it was like to go through a trial that could revolutionize cancer treatment: Scientists said the drug trial of the mRNA vaccine for melanoma could be the ...
washingtonpost.com/health/2026/08/23/meet-two-patients-who-tested-one-cancers-most-promising-breakthroughs/
Your tumour, your vaccine: How Moderna and Merck mRNA therapy could change cancer treatment
firstpost.com/lifestyle/your-tumour-your-vaccine-how-moderna-and-merck-mrna-therapy-could-change-cancer-treatment-14039506.html
‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial: The drug is based on the same messenger RNA (mRNA) technology behind Covid-19 vaccines ...
straitstimes.com/world/united-states/breakthrough-mrna-cancer-drug-curbs-melanoma-in-large-trial
Skin cancer vaccine: Moderna study meets targets - | Stock doubles: A novel skin cancer vaccine from Moderna has met its targets in a clinical trial ...
t-online.de/gesundheit/aktuelles/id_101396450/hautkrebs-impfstoff-moderna-studie-erreicht-ziele-aktie-verdoppelt-sich.html
Cancer therapy: Moderna reports positive results in study of skin cancer vaccine: Moderna has published positive study data on a novel melanoma vaccine ...
zeit.de/gesundheit/2026-08/mrna-krebsimpfstoff-moderna-merck-intismeran-keytruda-melanom
The Globe and Mail Aug 19
Merck, Moderna skin cancer vaccine reduces disease’s recurrence, spread in large trial
theglobeandmail.com/investing/article-merck-moderna-skin-cancer-vaccine-trial-results/
A Skin Cancer Vaccine May Be on the Horizon: An experimental mRNA vaccine may help delay or prevent melanoma recurrence when combined with traditional treatment ...
allure.com/story/skin-cancer-personalized-mrna-vaccine-trials
A personalized vaccine for melanoma cut the risk of cancer returning after five years
nbcnews.com/health/cancer/personalized-vaccine-melanoma-cut-risk-cancer-returning-five-years-rcna347424
nyulangone.org Jun 01
Cancer Vaccine Sustains 49 Percent Melanoma Reduction After 5 Years: NYU Langone Health study shows melanoma patients that vaccine therapy can demonstrably ...
nyulangone.org/news/cancer-vaccine-sustains-49-percent-melanoma-reduction-after-5-years
German mRNA Vaccine Offers Hope for Pancreatic Cancer: Pancreatic cancer has a poor prognosis; only slightly more than ten percent of patients survive longer ...
focus.de/gesundheit/news/deutsche-mrna-impfung-macht-hoffnung-bei-bauchspeicheldruesenkrebs_598518c5-5e0f-4c4d-bfa4-6146f829375a.html
,regionOfInterest=(838,819)&hash=d46be719765d032ed1f51e3c8d1b4b1f37ffbd081c79bdc26180ebed9c12fe47)
Moderna CEO hails breakthrough mRNA cancer vaccine that halves melanoma recurrence risk with Keytruda
foxbusiness.com/media/moderna-ceo-hails-breakthrough-mrna-cancer-vaccine-halves-melanoma-recurrence-risk-keytruda
COVID vaccines show an unexpected benefit: helping fight cancer: Scientists say mRNA technology could be setting up the immune system to fight deadly tumors—and ...
fastcompany.com/91427862/covid-vaccines-show-an-unexpected-benefit-helping-fight-cancer
MIT Spinout Strand Therapeutics Raises $153 Million To Make Cancerous Tumors Light Up
forbes.com/sites/amyfeldman/2025/08/07/mit-spinout-strand-therapeutics-raises-153-million-to-make-cancerous-tumors-light-up/
Next